SCHEMBL22924128

SCHEMBL22924128

Cc1n[nH]c2ccc(F)c(C(C)(C)Cn3nc(C4CC4)c4c(C(C)(C)C)c(F)ccc43)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22924125 0.86 — —
SCHEMBL24592411 0.83 — —
SCHEMBL22924153 0.83 PROKR1 (0.32) —
SCHEMBL18405899 0.75 CYP1A2 (0.32) —
SCHEMBL22349111 0.74 GRM4 (0.34) —
SCHEMBL22924139 0.72 — —
SCHEMBL24089504 0.66 — —
SCHEMBL22924152 0.65 — —
SCHEMBL22328034 0.63 TLR9 (0.33) —
SCHEMBL18408663 0.63 MAPT (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024501-A1 COVALENT INHIBITORS OF KRAS ARAXES PHARMA LLC 2021-01-28 — — US disclosed
Send feedback